# FDA recall D-0015-2016

> **Ferring Pharmaceuticals Inc** · Class III · drug recall initiated 2015-09-09.

## Product

Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (contains 5 single dose vials of Bravelle, 5 single dose vials of 0.9% Sodium Chloride Inj., USP, 2 mL, and 5 Q-Cap Vial Adaptors) , Rx Only, Manufactured for: Ferring Pharmaceuticals, Inc. Parsippany, NJ 07054, By: Ferring Gmbh, Kiel Germany, NDC 55566-8505-6

## Reason for recall

Subpotent Drug

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0015-2016
- **Recalling firm:** Ferring Pharmaceuticals Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-09-09
- **Report date:** 2015-10-21
- **Termination date:** 2020-11-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0015-2016

## Citation

> AI Analytics. FDA recall D-0015-2016. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0015-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*